Goldman Sachs’s LifeVantage LFVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$800K Sell
185,114
-15,108
-8% -$79.1K ﹤0.01% 5255
2025
Q4
$1.23M Buy
200,222
+150,785
+305% +$1.12M ﹤0.01% 4972
2025
Q3
$481K Buy
49,437
+4,866
+11% +$60.9K ﹤0.01% 5534
2025
Q2
$583K Buy
44,571
+53
+0.1% +$685 ﹤0.01% 5071
2025
Q1
$649K Buy
44,518
+8,762
+25% +$165K ﹤0.01% 5019
2024
Q4
$627K Buy
+35,756
New +$501K ﹤0.01% 5114
2021
Q3
Sell
-38,431
Closed -$282K 6384
2021
Q2
$282K Buy
38,431
+27,558
+253% +$225K ﹤0.01% 5554
2021
Q1
$102K Sell
10,873
-15,585
-59% -$145K ﹤0.01% 5839
2020
Q4
$247K Sell
26,458
-683
-3% -$7.67K ﹤0.01% 4982
2020
Q3
$328K Buy
27,141
+455
+2% +$6.15K ﹤0.01% 4686
2020
Q2
$361K Buy
26,686
+9,881
+59% +$137K ﹤0.01% 4539
2020
Q1
$173K Buy
16,805
+1,872
+13% +$25.6K ﹤0.01% 4754
2019
Q4
$233K Buy
+14,933
New +$220K ﹤0.01% 4844
2019
Q2
Sell
-114,974
Closed -$1.64M 5254
2019
Q1
$1.64M Buy
+114,974
New +$1.67M ﹤0.01% 3762
2017
Q3
Sell
-54,838
Closed -$237K 6763
2017
Q2
$237K Buy
54,838
+44,744
+443% +$197K ﹤0.01% 5679
2017
Q1
$54K Buy
+10,094
New +$63.7K ﹤0.01% 6264
2016
Q1
Sell
-11,551
Closed -$110K 7207
2015
Q4
$110K Buy
11,551
+1,327
+13% +$10K ﹤0.01% 6121
2015
Q3
$58K Sell
10,224
-482
-5% -$2.31K ﹤0.01% 6736
2015
Q2
$40K Buy
10,706
+4,796
+81% +$22.2K ﹤0.01% 6919
2015
Q1
$33K Sell
5,910
-2,471
-29% -$17.8K ﹤0.01% 6807
2014
Q4
$76K Sell
8,381
-13,553
-62% -$124K ﹤0.01% 6680
2014
Q3
$175K Buy
21,934
+5,731
+35% +$52.5K ﹤0.01% 6260
2014
Q2
$163K Sell
16,203
-13,653
-46% -$130K ﹤0.01% 6342
2014
Q1
$274K Buy
29,856
+21,982
+279% +$220K ﹤0.01% 5810
2013
Q4
$91K Buy
7,874
+5,973
+314% +$84.2K ﹤0.01% 6308
2013
Q3
$32K Sell
1,901
-32,020
-94% -$553K ﹤0.01% 6371
2013
Q2
$551K Buy
+33,921
New +$545K ﹤0.01% 4864

Other funds holding LFVN

Goldman Sachs's LFVN Position: Q1 2026 in Review

Goldman Sachs reduced its LifeVantage (LFVN) stake by 7.5% in Q1 2026, selling an estimated $79.1K and leaving 185,114 shares worth $800K. The position accounts for ﹤0.01% of the portfolio, ranked #5255.

Goldman Sachs first reported a position in LFVN in Q2 2013 and has held it in 27 quarters since. The position peaked at $1.64M in Q1 2019. 104 funds tracked by Wall St. Rank hold LFVN as of Q1 2026.

  • Goldman Sachs held 185,114 shares of LifeVantage worth $800K as of Q1 2026.
  • Goldman Sachs sold 15,108 LifeVantage shares in Q1 2026, an estimated $79.1K.
  • LifeVantage made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #5255 holding.
  • Goldman Sachs first reported a position in LifeVantage in Q2 2013 and has held it in 27 quarters since.
  • Goldman Sachs's LifeVantage position peaked at $1.64M in Q1 2019.
  • 104 funds tracked by Wall St. Rank held LifeVantage as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.